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Barcelona, SpainAbstract—Human Dopamine- and cAMP-regulated phos-
phoprotein of molecular weight 32 kDa (DARPP-32, also
known as PPP1R1B) gene codes for diﬀerent transcripts
that are mainly translated into two DARPP-32 protein iso-
forms, full length (ﬂ)-DARPP-32 and truncated (t)-DARPP.
The t-DARPP lacks the ﬁrst 36 residues at the N-terminal,
which alters its function. In the central nervous system,
ﬂ-DARPP-32 is highly expressed in GABAergic striatal
medium spiny neurons (MSNs), where it integrates
dopaminergic and glutamatergic input signaling. However,
no information about human DARPP-32 isoform expression
during MSNs maturation is available. In this study, our aim
is to determine the expression of the two DARPP-32 iso-
forms in human fetal and adult striatal samples. We show
that DARPP-32 isoform expression is diﬀerentially regulated
during human striatal development, with the t-DARPP iso-
form being virtually absent from whole ganglionic eminence
(WGE) and highly induced in the adult striatum (in both cau-
date and putamen). We next compared the four most com-
mon anti-DARPP-32 antibodies used in human specimens,
to study their recognition of the two isoforms in fetal and
adult human striatal samples by western blot and immuno-
histochemistry. The four antibodies speciﬁcally identify
the ﬂ-DARPP-32 in both fetal and adult samples, while
t-DARPP form was only detected in adult striatal samples.
In addition, the lack of t-DARPP recognition in human adult
striatum by the antibody generated against the full-length
domain produces in turn diﬀerent eﬃcacy by immunohisto-
chemical analysis. In conclusion, our results show thathttp://dx.doi.org/10.1016/j.neuroscience.2016.07.022
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320expression of human DARPP-32 protein isoforms depends
on the striatal neurodevelopmental stage with t-DARPP
being speciﬁc for the human adult striatum.  2016 The
Author(s). Published by Elsevier Ltd on behalf of IBRO. This
is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ment.INTRODUCTION
Human Dopamine- and cAMP-regulated phosphoprotein
of molecular weight 32 kDa (DARPP-32), also known as
Protein phosphatase 1 (PP1) regulatory subunit 1B
(PPP1R1B), is a phosphorylation-dependent inhibitor
regulated by cyclic nucleotide dependent protein kinases
(Yger and Girault, 2011). Its gene codes for alternative
splice transcripts that are translated in two main protein
isoforms, the full length DARPP-32 (204 a.a.) and the
truncated (t)-DARPP (168 a.a.) (El-Rifai et al., 2002).
The t-DARPP protein isoform lacks the aminoacidic
sequence 1-36 at the N-terminus (El-Rifai et al., 2002),
determining the loss of its function as a PP1 or PKA inhi-
bitor, although the consequences of this for cell signaling
are unclear. Interestingly t-DARPP is associated with
tumorigenesis, inducing cell proliferation and resistance
to apoptosis both in vitro and in vivo (El-Rifai et al.,
2002; Vangamudi et al., 2010; Christenson and Kane,
2014; Denny and Kane, 2015), whereas in the central
nervous system, t-DARPP increase in dorso-lateral pre-
frontal neocortex and hippocampus has been implicated
in the pathogenesis of schizophrenia and cognitive disor-
ders (Svenningsson et al., 2004; Kunii et al., 2011).
Within the brain, DARPP-32 is mainly expressed by
regions receiving dopaminergic projection, such as
caudate, putamen, nucleus accumbens, cerebral and
cerebellar cortex (Ouimet et al., 1984; Berger et al.,
1990; Brene´ et al., 1994, 1995). Neuronal DARPP-32
protein works as functional integrator of glutamatergic
and dopaminergic inputs (Svenningsson et al., 2004). In
fact, dopamine or glutamate stimulation induces diﬀeren-
tial signaling cascades that trigger alternative phosphory-
lation pattern of Thr 34 and Thr 75 residues of DARPP-32
protein, regulating the ability of DARPP-32 to interact with
multifunctional serine/threonine phosphatases (Bibb
et al., 1999; Svenningsson et al., 2004; Fernandez
et al., 2005; Yger and Girault, 2011).ons.org/licenses/by-nc-nd/4.0/).
Table 1. Human tissue information. PMD = post mortem delay; pcd = post conceptional days; y.o. = years old; n.a. = not available
Gender Age PMD Tissue
n.a. 49 pcd n.a. WGE, Cortex
n.a. 51 pcd n.a. WGE, Cortex
n.a. 53 pcd n.a. WGE, Cortex
n.a. 53 pcd n.a. WGE
n.a. 53 pcd n.a. WGE, Cortex
n.a. 55 pcd n.a. WGE
n.a. 57 pcd n.a. WGE
n.a. 59 pcd n.a. WGE, Cortex
n.a. 61 pcd n.a. WGE, Cortex
n.a. 63 pcd n.a. WGE, Cortex
Male 31 y.o. 17 h 30 min Caudate, Putamen, Motor cortex, Hippocampus, Cerebellum
Male 39 y.o. 3 h 30 min Caudate, Putamen, Motor cortex, Hippocampus
Female 60 y.o. 15 h 30 min Caudate, Putamen, Motor cortex
Male 64 y.o. 3 h 30 min Caudate, Putamen, Motor cortex, Hippocampus
Female 68 y.o. 13 h Caudate, Putamen, Motor cortex, Cerebellum
Female 71 y.o. 8 h 30 min Caudate, Motor cortex, Hippocampus,
Female 81 y.o. 23 h 30 min Caudate, Putamen, Motor cortex, Cerebellum
Female 86 y.o. 12 h 20 min Caudate, Putamen
M. Straccia et al. / Neuroscience 333 (2016) 320–330 321Human neostriatum is anatomically composed of the
caudate and putamen nuclei and is mainly populated by
GABAergic medium-sized spiny neurons (MSNs), which
highly express DARPP-32 from an early stage of fetal
development (Hemmings and Greengard, 1986; Kang
et al., 2011; Onorati et al., 2014). Furthermore, MSNs
are the most vulnerable type of neurons in Huntington’s
disease (HD) (Graveland et al., 1985; Vonsattel et al.,
1985), an autosomal dominant monogenic disease. In
recent years stem cell research has attempted to gener-
ate MSNs by diﬀerentiating human pluripotent stem cell
(hPSC) in order to study HD pathogenesis, as well as to
generate donor cells for cell replacement, and for drug
screening. The use of DARPP-32 as speciﬁc MSN marker
has been crucial to follow the generation of hPSC-derived
MSNs (Aubry et al., 2008; El-Akabawy et al., 2011; Carri
et al., 2012; Ma et al., 2012; Straccia et al., 2015; The HD
iPSC Consortium, 2012; Victor et al., 2014). However, to
our knowledge no information about striatal DARPP-32
isoform expression in human MSNs development is avail-
able in the literature.
In this study, we demonstrated that the expression of
DARPP-32 transcript variants and the respective protein
isoforms has a time-dependent regulation. In addition,
we highlighted that the four antibodies are not
equivalent in recognizing DARPP-32 isoforms in adult
human putamen and caudate nuclei. In conclusion, we
propose t-DARPP as more speciﬁc marker to identify
fully mature MSNs.EXPERIMENTAL PROCEDURES
Human brain tissue
Adultmotor neocortex, hippocampus, cerebellum, caudate
andputamen sampleswere obtained from theNeurological
Tissue Bank of the Biobank-Hospital Clı´nic-Institut
d’Investigacions Biome`diques August Pi i Sunyer
(IDIBAPS; Barcelona, Spain; URL: www.clinicbiobanc.
org), following the guidelines and approval of the localethics committee. DARPP-32 positive cells are detected
in human fetal forebrain, speciﬁcally in ganglionic
eminence post-mitotic areas, in fetuses older than six
post conceptionweeks (p.c.w.) (Naimi et al., 1996). Conse-
quently fetuses (CRL of 22–54 mm) ranging in age from 7
to 9 p.c.w were collected by donation of the elective termi-
nation of pregnancy through the South Wales (UK) Initia-
tive for Fetal Tissue Transplantation (‘‘SWIFT”) program,
with full ethical approval (02/4446), as source ofMSNs pro-
genitors (Kopyov et al., 1998; Hauser et al., 2002; Rosser
et al., 2002). FormRNAstudies, neocortical and striatal pri-
mordia were processed as previously published (Kelly
et al., 2011). Further details on human tissue used in this
study are in Table 1 and previously published (Straccia
et al., 2015).RNA isolation, retrotranscription and quantitative
real time PCR
Total RNA was isolated using TRI Reagent (Sigma–
Aldrich T9424) following the manufacturer’s protocol. In
brief, 1 lg of RNA for each condition was reverse
transcribed using PrimeScript RT reagent kit (Takara,
RR037A). cDNA was diluted to 5 ng/lL and 2 lL were
used to perform quantitative real-time PCR (qPCR).
PrimeTime qPCR assays for PPP1R1B isoforms
(see Table 2) were used as recommended by
provider (IDT technologies). B2M (NM_004048; Hs.
PT.39a.22214845), HPRT1 (NM_000194; Hs.PT.51.
2145446) RPL13A (NM_012423; Hs.PT.51.21531404)
and HSP90AB1 (NM_007355; IDT Hs.PT.56a.
38913643.gs) mRNA levels were not altered (data not
shown) and were used as reference genes. QPCR was
carried out with Premix Ex Taq (Takara, RR390A) in
6 lL of ﬁnal volume using CFX384-C1000 Thermal
Cycler equipment (Bio-Rad). Samples were run for 40
cycles (95 C for 5 s, 60 C for 20 s). Relative gene
expression values were calculated using Bio-Rad CFX
manager software (Bio-Rad).
Table 2. QPCR probes used to detect the speciﬁc DARPP-32 transcript variants
Description IDT Technologies reference Exons detection Variants detection Amplicon
DARPP-32 Hs.PT.56a.2727270 1-3 1 127 bp
t-DARPP Hs.PT.56a.23169336 1b-5 2-3 138 bp
Total DARPP-32 Hs.PT.56a.40063116.g 5-6 1-2-3 135 bp
Table 3. List of the comprehensive revision of the anti-DARPP-32 antibodies used for immunodetection of human DARPP-32 in the literature. The
antibodies used in this study are highlighted in bold. Ordered by provider name. (aa = aminoacids; FACS = Fluorescence-activated cell sorting;
IHC = Immunohistochemistry; ICC = Immunocytochemistry; MSN= Medium spiny neurons; n.s. = not speciﬁed; hPSC = human pluripotent stem
cells)
Clone Epitope Species Provider Catalog
n
Assay Human Sample References
15 aa: 70-181 Human BD 611520 IHC Adult brain Brito et al. (2013)
19A3 Glu160 region Human Cell Signaling 2306 ICC hPSC-derived MSNs The HD iPSC Consortium (2012)
n.s. n.s. n.s. Cell Signaling n.s. IHC,
FACS
Adult brain Ernst et al. (2014)
n.s. aa: 23-37 synthetic Chemicon AB1656 ICC STROC05-derived MSNs Ishikawa et al. (2007); El-
Akabawy et al. (2011)
n.s. n.s. n.s. Chemicon/
Merck Millipore
n.s ICC hPSC-derived MSNs Ma et al. (2012)
EP720Y N-terminus Human Epitomics/
Abcam
Ab40801 IHC;
ICC
Fetal brain, hPSC-derived
MSNs
Carri et al. (2012), Onorati et al.
(2014)
H-62 aa: 134-196 Bovine Santa Cruz SC-
11365
IHC Fetal brain The HD iPSC Consortium (2012),
Pauly et al. (2013)
15 aa: 70-181 Human Santa Cruz SC-
135877
IHC Fetal brain Onorati et al. (2014)
n.s. n.s. n.s. Santa Cruz n.s. ICC hPSC-derived MSNs;
Fibroblast-derived MSNs
Aubry et al. (2008), Victor et al.
(2014)
n.s. n.s. n.s. Santa Cruz n.s. IHC Adult brain Kunii et al. (2011)
Table 4. Description of the four anti-DARPP-32 antibodies selected for the study. (n.a. = not available)
Manufacturer Cell Signaling Santa Cruz BD Laboratories Abcam
Reference 2306 SC-11365 611520 Ab40801
Clone 19A3 H-62 15/DARPP-32 EP720Y
Source Rabbit Rabbit Mouse Rabbit
IgG IgG IgG1 IgG
Peptide antigen Glu160 region aa 134-195 aa 70-181 N-terminus
Origin Human Bovine Human Human
Mono/Poly-clonal Monoclonal Polyclonal Monoclonal Monoclonal
WB Dilution (ﬁnal titer) Fetal 1/100 1/1000 1/100 1/5000
Adult 1/1000 (n.a.) 1/10000 (200 ng/mL) 1/1000 (250 ng/mL) 1/50,000 (n.a.)
322 M. Straccia et al. / Neuroscience 333 (2016) 320–330Protein extraction and Western Blot
Total protein extract was isolated from human tissue
using TRI Reagent (Sigma–Aldrich T9424) according to
the manufacturer’s protocol. Total protein extracts were
denatured using 2.5 mM dithiothreitol at 95 C for 5 min
and then 10–40 lg of each denatured samples was
subjected to 12% SDS–PAGE and transferred to a
nitrocellulose membrane (Millipore, IPVH00010) for
60 min at 2,5 mA/cm2 as described previously (Straccia
et al., 2013). Membranes were incubated with the
DARPP-32 primary antibodies as indicated in Table 4
and monoclonal mouse anti-Tubulin (Sigma–Aldrich,
T9026), diluted in immunoblot buﬀer (TBS containing
0.05% Tween-20 and 5% no-fat dry milk). For antibodies
comparative analysis to minimize technical variability,20 lg of total protein tissue extract from the same donor
were loaded in each of the four lanes of the SDS–PAGE.
To show similar signals, western blot exposures times
were calibrated; for WGE samples, 19A3, EP720Y and
H62 were exposed for about 10 s, while clone 15 (BD
611520) was exposed 3 min; for adult samples, 19A3,
EP720Y, H62 and 15 anti-DARPP-32 antibodies clones
were exposed for about 2 s, 10 s, 12 s and 3 min, respec-
tively. For competition assay, 20 lg of WGE and striatum
were separated by 10% SDS–PAGE and immunodetec-
tion was performed in parallel incubating the antibody with
or without the blocking peptide. Anti-DARPP32 antibody
(Abcam Ab40801) was diluted in immunoblot buﬀer with
or without the presence of 1 lg/ml Blocking Peptide
(Abcam, Ab189245). Anti-rabbit (Promega, W401B) and
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M. Straccia et al. / Neuroscience 333 (2016) 320–330 323Anti-mouse (Promega, W402B) HRP-conjugated sec-
ondary antibodies were used at 1:5000 dilution. Chemilu-
minescent detection was performed incubating for 2 min
with Luminata Classico western HRP substrate (Millipore,
WBLUC500) and exposing for 1–10 s with Fuji Medical
X-Ray Film Super RX-N (Fujiﬁlm, 47410 19289).
We performed western blots quantiﬁcation by ImageJ
Gel Analysis plug-in on digital acquired ﬁlms.
Immunohistochemistry
Five-lm thick sections were obtained from deep-frozen
tissue blocks (80 C), cryopreserved tissue (ﬁxed for
24 h in 4% paraformaldehyde followed by immersion in
30% sucrose for 24 h and frozen at 80 C), and 4%
formalin-ﬁxed and paraﬃn-embedded tissue blocks from
the putamen and caudate nucleus of a neurologically
healthy brain donor at the Neurological Tissue Bank of
the Biobank-Hospital Clinic-IDIBAPS, after obtaining
informed consent for the use of brain tissue for
diagnostic and research purposes. Immunohisto-
chemistry was performed on an automated
immunostainer (DAKO autostainer plus) using the
antibodies in Table 5. Immunoreaction was visualized
using the DAKO Envision system. For antigen retrieval,
paraﬃn sections were dewaxed and several pre-
treatment methods were tested: immersion in 98%
formic acid for 5 min, boiling of sections in a microwave
for 20 min in citrate buﬀer at pH 6 or in EDTA at pH 9,
or a combination of both (98% formic acid + citrate
buﬀer pH 6 or EDTA pH 9). The best results were
obtained by boiling the sections in a microwave for
20 min in citrate buﬀer at pH 6. The following lots of
Anti-DARPP-32 EP720Y clone were used: GR96296-1
and GR96296-7 from Abcam Ab40801; Y1032103D2
from Epitomics cat. n1710-1.
Sampling and statistics
Caudate and putamen samples from the same donor did
not show signiﬁcant diﬀerences in our analysis, for this
reason they are considered as one biological sample
after within-patient averaging. Data were analyzed using
GraphPad Prism version 6.0c for Mac, GraphPad
Software, La Jolla, California, USA (www.graphpad.com).
Samples were tested for the normality and equality of
variance. Unpaired two-tailed Mann–Whitney non-
parametric test has been performed to test independent
observations between two biological groups. Each
biological group is composed of diﬀerent donors’
samples. Values of p< 0.05 were considered statistically
signiﬁcant.
RESULTS
DARPP-32 transcript variants in adult human brain
regions
DARPP-32 expression has been largely characterized in
mouse CNS development (Foster et al., 1988); however,
its characterization in human development has been less
explored due to specimens availability. In adult human
post-mortem brain, DARPP-32 mRNA is highly expressed
Fig. 1. (A) Schematic representation of PPP1R1B (DARPP-32) gene
structure and its mRNA transcripts with the respectively translated
protein isoforms. Human DARPP-32 and t-DARPP proteins are
represented with their modiﬁcation sites as predicted by Phos-
phoSitePlus (Hornbeck et al., 2015). (B) QPCR analysis of PPP1R1B
splice variants expressed in human striatum (Str), motor neocortex
(Ctx), hippocampus (Hip) and cerebellum (Cer). Individual values are
plotted with median. (C) A representative western blot of three
independent experiments is presented to show the relative DARPP-
32 isoforms at protein level between the human brain regions under
consideration (anti-DARPP-32 antibody, Clone 19A3). Ratio of
DARPP-32/t-DARPP isoforms in human brain regions is analyzed
by western blot (a representative one in D) for striatum (n= 4), motor
neocortex (n= 4), hippocampus (n= 3) and cerebellum (n= 3).
Quantiﬁcation is showed as scatter dot plot in E.
324 M. Straccia et al. / Neuroscience 333 (2016) 320–330in basal ganglia and choroid plexus than in neocortex and
hippocampus, with a speciﬁc expression also in the Purk-
inje layer of cerebellum (Brene´ et al., 1994). DARPP-32
gene, namely PPP1R1B, has eight exons and codes for
three diﬀerent transcript variants (Fig. 1A). Full length
DARPP-32 mRNA (transcript variant 1; NM_032192.3)
does not include exon 1b and is translated into full length
DARPP-32 protein of 204 aminoacids (aa). Transcript
variants 2 (NM_181505.3) and 3 (NM_001242464.1)
include the exon 1b with exon 1 being skipped. The two
transcript variants diﬀer on their Transcription Start Site
in exon 1b (1bV2 versus 1bV3). However both variants
translation begins in the same ATG located in exon 2,
giving rise to the same truncated DARPP-32 protein
(t-DARPP) of 168 aa. The expression levels for DARPP-
32 transcript variants in adult human brain have been
investigated in dorso-lateral prefrontal neocortex, hip-
pocampus and caudate (Kunii et al., 2014). However, a
direct comparison between the DARPP-32 transcripts or
protein isoforms was not described as we characterize
in the present work.
To analyze the levels of mRNAs that are translated in
the two diﬀerent DARPP-32 protein isoforms, we haveused three speciﬁc qPCR probe-based assays that
recognize transcript variant 1 (DARPP-32), transcript
variants 2-3 (t-DARPP) and all transcript variants (total
DARPP-32), respectively (Table 2). Hence we show the
levels of the DARPP-32 transcript variants in adult
human motor neocortex, hippocampus, striatum
(caudate-putamen nuclei) and cerebellum (Fig. 1B). No
statistical diﬀerences in the expression of both transcript
variants were observed between the adult caudate and
putamen regions, indicating similar regulation of
PPP1R1B gene expression. For this reason we refer
them as striatum from now onward. Motor neocortical
(DARPP-32 = 17,16 ± 10,85; t-DARPP= 0,21
± 0,14), hippocampal (DARPP-32 = 4,45 ± 1,42;
t-DARPP= 0,05 ± 0,01) and cerebellar (DARPP-
32 = 7,80 ± 7,59; t-DARPP= 0,15 ± 0,03) samples
displayed similar gene expression levels for both
DARPP-32 transcript variants. On the other hand,
striatum showed higher mRNA levels for DARPP-32
transcripts (DARPP-32 = 79,31 ± 25,63; t-DARPP= 1,
38 ± 0,72). To verify this result at protein levels, we
determine the relative contribution of DARPP-32 protein
isoforms by western blot analysis (Fig. 1C). Striatum
showed higher expression of both DARPP-32 isoforms
compared to the other regions mirroring the gene
expression analysis. We extended the DARPP-32
protein isoforms analysis in order to determine the
relative ratio (t-DARPP/DARPP-32) in each region,
since it could be important for the cellular signaling
integration (Fig. 1D and E). Striatum showed a
consistent ratio of about 1:1 between isoforms
compared to the other brain regions, where DARPP-32
isoform ratio was more variable. Only in one out of three
cerebellar samples we could detect some t-DARPP.
The t-DARPP isoform is highly induced in human
adult striatum
Next we characterized total DARPP-32 gene expression
in human striatal development, speciﬁcally in whole
ganglionic eminence (WGE) at 49 and 63 days post-
conception (pcd) and in post-mortem striatum of
individuals between 31 and 71 years old. Human WGE
showed detectable mRNA expression of total DARPP-
32 (Fig. 2A) as already demonstrated elsewhere by
immunocytochemistry (Onorati et al., 2014). In addition,
we showed that total DARPP-32 mRNA levels were sig-
niﬁcantly increased (p< 0,0001; two-tailed unpaired
Mann–Whitney test) of about 18 folds in the adult striatum
(n= 6) relative to WGE (n= 12) (Fig. 2A).
We also compared the mRNA levels of full length
DARPP-32 (tr. var. 1) and t-DARPP variants (tr. var. 2-
3) in human WGE versus adult striatum (Fig. 2B), using
a probe recognizing all DARPP-32 mRNAs (tr. var. 1-2-
3) as reference for normalization (Table 2). DARPP-32
transcript variant was signiﬁcantly up-regulated
(p= 0,0002; two-tailed unpaired Mann–Whitney test) in
adult striatum (n= 6) compared to WGE (n= 12),
which showed low expression of DARPP-32 gene.
Interestingly t-DARPP transcripts expression is
proportionally more highly induced (fetal mean
Ct = 33,9 ± 4,0; adult mean Ct = 26,0 ± 1,9) in adult
Fig. 2. QPCR analysis of total PPP1R1B gene expression in human
WGE and adult striatum (A); ***p< 0,001 when comparing total
DARPP-32 gene expression between WGE and striatum. Analysis of
expression of the speciﬁc DARPP-32 transcript variants by qPCR in
WGE and striatum (B); ***p< 0,001 when comparing the same
transcript variant between WGE and striatum; ##p< 0,01
###p< 0,001 when comparing DARPP-32 versus t-DARPP in the
same stage. Representative semi-quantitative PCR analysis of
PPP1R1B splice variants in two samples per each developmental
stage (C). A representative western blot of four independent exper-
iments shows protein expression of DARPP-32 isoforms in human
WGE and adult striatum (D). Cell Signaling anti-DARPP-32 antibody
(Clone 19A3, catalog n2306) also detected an unidentiﬁed reactive
(*) band in WGEs. Tubulin was used as loading control to perform
relative quantiﬁcation (E), **p< 0,01 when comparing t-DARPP
between WGE and striatum. Error bars are presented as standard
error of the mean (SEM).
Fig. 3. Tested antibodies are not equivalent for the detection of both
DARPP-32 protein isoforms. The alignment of mouse, bovine and
human protein sequences shows at the N-terminus the conserved
RVxF domain (shaded green), the potential PP-1 interaction domain
(shaded blue) and the Thr 34 (shaded violet) (A). Orthologs
conserved aa are depicted in red, while the diﬀerent aa between
species are in blue. Blue box shows the epitope for the Abcam
Ab40801 antibody at the N-terminus of DARPP-32 full-length isoform.
BD 611520 (black box), Santa Cruz SC-11365 (red box) and Cell
Signaling 2306 (green box) epitopes are localized in the shared
aminoacidic sequence of DARPP-32 and t-DARPP (A). Immune-
detection signals by Western blot (B) of diﬀerent amounts of loaded
protein (10–40 lg) from the same original human adult cerebellar
sample with the four diﬀerent antibodies anti-DARPP-32 under
analysis. Antibodies incubation conditions are indicated in Table 4.
Ponceau-S staining of blotted membrane showed the total amount of
protein transferred from each lane of the 12% SDS–PAGE. (C)
Western blot comparative analysis of the four antibodies under
consideration in WGE or adult striatal sample. Representative of ﬁve
independent experiments. Adult caudate nuclei and putamen express
both full-length DARPP-32 (red arrow head) and t-DARPP (black
arrow head). However Abcam Ab40801 clone EP720Y was not able
to identify t-DARPP (white arrowhead). Competition assay for
EP720Y clone (Abcam Ab40801) (D); the presence of the blocking
peptide abrogated any bands immunoreactivity due to anti-DARPP-
32 incubation. Tubulin immunodetection has been used as control.
(For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
M. Straccia et al. / Neuroscience 333 (2016) 320–330 325striatum compared to full-length DARPP-32 variant (fetal
mean Ct = 27,5 ± 3,7; adult mean Ct = 21,5 ± 1,4)
(Fig. 2B and C) (p= 0,0001; two-tailed unpaired
Mann–Whitney test). However the relative quantity of
DARPP-32 (tr. var. 1) was signiﬁcantly higher compared
to t-DARPP (tr. var. 2-3) mRNAs levels in both WGE
p< 0,0001; two-tailed unpaired Mann–Whitney test)
and adult striatum (p= 0,0022; two-tailed unpaired
Mann–Whitney test). To further study if these
transcriptional changes during human striatal
development were mirrored at protein level, we
analyzed DARPP-32 isoforms by western blot (Fig. 2D).
The t-DARPP isoform was not detected in any WGE
sample (Fig. 2D), while in adult human striatal samples
its expression was signiﬁcantly induced (p< 0,0091;
two-tailed unpaired Mann–Whitney test; Fig. 2E).
T-DARPP has no signiﬁcant diﬀerences with the full-
length DARPP-32 protein isoform levels in adult striatum
(Fig. 2D and E). Furthermore DARPP-32 isoform was
not signiﬁcantly increased (p= 0,1; two-tailed unpaired
Mann–Whitney test) in adult human striatum (n= 9)
compared to WGE (n= 4) (Fig. 2D and E), discordantly
to its transcript up-regulation.
326 M. Straccia et al. / Neuroscience 333 (2016) 320–330Antibodies against DARPP-32 are not equivalent for
detection of DARPP-32 isoforms in adult human
neostriatum
T-DARPP is highly induced in adult human striatum as we
show in Fig. 2B. In view of this we tested diﬀerent
antibodies to verify their eﬃcacy in detecting DARPP-32
isoforms. We reviewed the literature searching for anti-
DARPP-32 antibodies used in human specimens
(Table 3). We found only ﬁve antibodies properly
referenced (Carri et al., 2012; The HD iPSC
Consortium, 2012; Brito et al., 2013; Pauly et al., 2013;
Onorati et al., 2014); two of them were raised against
the same epitope, so we ﬁnally chose four anti-DARPP-
32 antibodies from diﬀerent providers to test (Table 4).
The four antibodies that we selected are generated using
diﬀerent antigenic peptides (Tables 3 and 4), one of them
being a bovine sequence (Clone H62, Santa Cruz). The
alignment of mouse, bovine and human protein
sequences with diﬀerent color boxes (Fig. 3A) indicates
the distinct epitopes that are recognized by the four anti-
bodies under consideration. Anti-DARPP-32 clone
EP720Y (Ab40801, Abcam) recognizes the N-terminus
of DARPP-32 and therefore, it cannot detect the
t-DARPP.
We ﬁrst compared the anti-DARPP-32 antibodies’
sensitivity (Fig. 3B). Anti-DARPP-32 clone EP720Y
showed the highest sensitivity detecting 10 micrograms
of total protein extract with strong signal, followed by
clone 19A3, H62 and 15, respectively. Thereafter, we
tested the four antibodies by western blot in human total
protein tissue extract of WGE and adult caudate and
putamen nuclei. WGE samples (n= 5 of diﬀerent
donors) did not show detectable t-DARPP protein
(Fig. 3C), while all four antibodies detected DARPP-32
protein in fetal samples (Fig. 3C). Adult human caudate
and putamen nuclei showed protein expression of both
DARPP-32 and t-DARPP (Fig. 3C). However, as
predicted by the alignment (Fig. 3A), clone EP720Y did
not detect t-DARPP neither in caudate nor in putamen
total protein extract.
Several other protein bands were immune detected
with a similar pattern by the four antibodies in all diﬀerent
samples we tested, with the EP720Y clone being the
antibody with the greatest number of unidentiﬁed
immunoreactive signals (Fig. 3D). We next examined if
those signals could be due to secondary antibody cross-
reaction. In order to verify this possibility we performed a
competition assay for the fetal WGE and the adult human
striatal tissues. The presence of the immunogenic
peptide completely blocked the immunodetection of any
protein bands (Fig. 3C), suggesting that the EP720Y
antibody detects the other protein signals as speciﬁc by
western blot. Further experiments are required to
determine the identity of these proteins.Anti DARPP-32 antibodies are not equivalent for
immunostaining detection of DARPP-32 in adult
human striatal MSNs
So far we have demonstrated that adult human striatal
tissues express high levels of both DARPP-32 proteinisoforms in contrast with WGE. Furthermore, we
showed that the four antibodies against DARPP-32 are
not equivalent by western blot. Next, we tested the
eﬃcacy of these antibodies in identifying MSNs in adult
human striatum in several diﬀerent conditions by
immunohistochemistry (Table 5). EP720Y anti-DARPP-
32 antibody failed to stain MSNs or any other type of
cells in all the tested conditions in adult post-mortem
brain samples. To conﬁrm this result and to exclude any
other technical issue related to the speciﬁc batch of
EP720Y antibody, we tested three diﬀerent batches with
the same negative outcome. On the other hand, the
other three DARPP-32 antibodies speciﬁcally stained
MSNs showing clear staining of MSNs’ soma and ﬁbers
through-out the striatal parenchyma. Finally, we chose
as the best condition human paraﬃn-embedded
samples treated with citrate buﬀer at pH = 6 (Fig. 4A, B
and Table 5). With these conditions, clones 19A3, H62
and 15 of anti-DARPP-32 antibodies stained with
diﬀerent eﬃcacy the adult human striatal MSNs
(Fig. 4A). All three antibodies neatly identiﬁed DARPP-
32 on the cell bodies of MSNs in both putamen and
caudate nuclei (Fig. 4B). Clone 19A3 staining is more
intense and sharp, allowing to perfectly distinguishing
projections and processes in continuity with the MSN
soma. Clones H62 and 15 show more similar staining
patterns, less intense and contrasted with the
background that allows appreciation of the nucleus
within the neuronal body.DISCUSSION
Deciphering the diﬀerential spatio-temporal expression of
DARPP-32 isoforms helps to better understand the
integration of glutamate and dopamine signaling during
human neurodevelopment. At the cellular level, it is
important to understand how DARPP-32 isoforms
aﬀecting cell physiology, especially in MSNs where
DARPP-32 is highly expressed. In recent years, stem
cell research has attempted to generate in vitro human
GABAergic MSNs from hPSC, with the identiﬁcation of
hPSC-derived MSNs mainly based on DARPP-32
immunostaining (Aubry et al., 2008; El-Akabawy et al.,
2011; Ma et al., 2012). This is colocalized with CTIP2
(BCL11B) and GABA by some authors (Danjo et al.,
2011; Carri et al., 2012), based on rodents striatal biology
(Arlotta et al., 2008) and on human fetal brain data (Carri
et al., 2012; Onorati et al., 2014). However, striatal
mRNAs and proteins expression could be diﬀerent in
the adult human brain.
Here we focus our analysis on DARPP-32 expression
in human brain, especially in fetal and adult human
striatum. We show that DARPP-32 total gene
expression is highly increased in human adult striatum
and that its transcripts’ levels are higher compared to
other adult brain regions, as also shown by
transcriptomic results in Human Brain Atlas [www.
hbatlas.org; (Kang et al., 2011)] and Allen Human Brain
Atlas (Hawrylycz et al., 2012; Sunkin et al., 2013). Fur-
thermore, we demonstrate that t-DARPP is markedly
increased in adult caudate-putamen nuclei, suggesting a
Fig. 4. Immunohistochemical comparative analysis of anti-DARPP-32 antibodies in human adult striatum. Representative microphotographs of
paraﬃn-embedded samples (same donor) unmasked with citrate buﬀer pH = 6 are shown at diﬀerent magniﬁcations (A). Antibodies were tested at
diﬀerent dilutions, here 1:250 dilution is shown, except for Abcam Ab40801 (EP720Y), which shows the condition of 1:50 dilution. The whole striatal
section is shown at arbitrary magniﬁcation (a.m.) to show the tissue integrity. Photo magniﬁcation of 20 (bars = 200 lm) and 100
(bars = 50 lm). (B) Representative MSNs’ microphotographs (bars = 20 lm).
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during adulthood. Interestingly we found a diﬀerence in
the ratio DARPP-32/t-DARPP between mRNAs and pro-
teins. At gene expression level t-DARPP transcripts are
relatively low expressed compared to DARPP-32 tran-
script, whereas at protein level isoforms are equally
expressed. Future studies with larger sample population
could better clarify this observation. However discrepan-cies between mRNA and protein levels were studied
and reported in human cell biology (Guo et al., 2008;
Gry et al., 2009).
Abnormal expression of t-DARPP transcripts in
human brain are associated with schizophrenia and
aﬀective disorders (Kunii et al., 2014). However, little is
known about t-DARPP subcellular localization and physi-
ological function in human CNS. The t-DARPP protein
328 M. Straccia et al. / Neuroscience 333 (2016) 320–330lacks the ﬁrst 36 residues of N-terminus, which include
the phosphorylation site Thr 34 and the PP-1 interacting
domain. For this reason t-DARPP predicted molecular
weight is 18,7 kDa (www.uniprot.org). However we
detected its speciﬁc immune-signal migrating around
28 kDa, as previously described (Belkhiri et al., 2008),
which may be most likely due to post-translational modiﬁ-
cation similarly to full length isoform DARPP-32. The con-
sistent detection of this protein signal by three diﬀerent
antibodies in several adult biological samples without
clear diﬀerences due to sex, age and post mortem delay
reinforces previous observations from El-Rifai’s research
group in cancer cells (Belkhiri et al., 2008).
T-DARPP cannot inhibit PP-1, but it could target CREB
mediating an alternative integration of dopaminergic-
glutamatergic inputs in human adult MSNs, as suggested
by observations in cancer cells (Gu et al., 2009; Yger and
Girault, 2011). In this view, t-DARPP up-regulation in
mature MSNs would increase the complexity of signaling
integration of this hub protein in the human striatum.
Interestingly, the stimulation of D1R in the direct
pathway and A2A receptor activation in the indirect
pathway triggers the phosphorylation of DARPP-32 on
the Thr34 (Lindskog et al., 2002; Shen et al., 2013), deter-
mining an enrichment of DARPP-32 in MSNs nuclei
in vitro and the consequent inhibition of nuclear PP-1 with
pleiotropic eﬀects (Stipanovich et al., 2008). One eﬀect is
that Histone 3 phosphorylation on Ser 10 is not removed,
determining long-term eﬀects on transcription through
chromatin decondensation (Stipanovich et al., 2008).
Although we cannot determine t-DARPP protein levels
in between the discrete fetal and adult stages here ana-
lyzed, we can hypothesize that the increase in t-DARPP
during striatal maturation could imply less DARPP-32 to
the nucleus and more condensed chromatin. And this
could represent a switch from the highly active transcrip-
tion of neuronal development toward a mature and func-
tional MSNs transcriptional program. Furthermore,
DARPP-32 into the nucleus has been described to directly
interact with the splicing factor tra2-beta1 in competition
with PP-1 in non-striatal cells (Benderska et al., 2010).
This nuclear DARPP-32 interaction with tra2-beta1 could
modify the alternative splicing program as it was sug-
gested elsewhere (Benderska et al., 2010). In a neurode-
velopmental perspective, alternative splicing determines
the speciﬁcations of the diﬀerent neuronal subtypes and
creates variability, which is needed for brain plasticity
(Li et al., 2007; Zheng and Black, 2013). The increase
in t-DARPP isoform in mature MSNs could tune the stri-
atal alternative splicing highly required for speciﬁcation
and connectivity establishment, but less needed in mature
circuitry.
Although from a practical point of view t-DARPP
seems to be a better marker to follow MSNs maturation,
it is not possible to generate antibodies against the
truncated-DARPP-32 based on the aminoacidic
sequence and ignoring its 3D structure, since its
peptidic sequence is completely shared by the full-
length isoform. Several anti-DARPP-32 antibodies have
been reported in the literature for their eﬃcacy to stain
human striatal specimens at diﬀerent developmentalstages. However, anti-DARPP-32 antibodies are not
always properly speciﬁed in research manuscripts (i.e.
commercial catalog number), preventing the proper
identiﬁcation of the speciﬁc antibody used. Considering
this, we undertook the immunohistochemical
comparison of the four antibodies on post-mortem adult
human striatum. Although Abcam Ab40801 clone
EP720Y antibody was successfully used in previous
immunohistochemical analysis of human fetal
telencephalon (Carri et al., 2012; Onorati et al., 2014)
and we also show that it works for western blot, we could
not detect any staining in adult human post-mortem brain
in any of the tested conditions. This negative result could
be due to a sensitivity problem of this antibody, since here
we show that about 50% of total DARPP-32 protein con-
tent is the t-DARPP, which cannot be recognize by this
speciﬁc antibody. The remaining antibodies we tested
did speciﬁcally recognize MSNs in adult human
caudate-putamen with subtle technical diﬀerences.
Finally, speciﬁc t-DARPP detection through new antibod-
ies, based on any conformational diﬀerence of this
isoform compared to the full-length, would allow to better
following the maturation of MSNs, but also will allow the
biochemical dissection of its function inside the cell.
CONCLUSIONS
To date, information on DARPP-32 isoforms expression
during human striatal development is limited. Here we
show an increase in DARPP-32 gene expression in
human adult striatum compared to WGE, with the
t-DARPP isoform being the most induced in the human
adult MSNs. The augmented level of t-DARPP in adult
striatum suggests an altered integration of
neurotransmission signals inside the MSNs and/or a
change in the mature MSN transcriptional program.
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